{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:52:20Z","timestamp":1761173540126,"version":"build-2065373602"},"reference-count":67,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.purol.2014.07.002","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T23:02:40Z","timestamp":1409094160000},"page":"1030-1040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Traitements non chirurgicaux des tumeurs de la voie excr\u00e9trice sup\u00e9rieure\u00a0: \u00e9tat-de-l\u2019art pour le rapport annuel de l\u2019Association fran\u00e7aise d\u2019urologie"],"prefix":"10.1016","volume":"24","author":[{"given":"F.","family":"Audenet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Hou\u00e9d\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Colin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.purol.2014.07.002_bib0005","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/S1166-7087(13)70050-2","article-title":"Recommandations en onco-urologie 2013 du CCAFU\u00a0: tumeurs de la voie excr\u00e9trice urinaire sup\u00e9rieure","volume":"23","author":"Pfister","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0010","first-page":"333","article-title":"Adjuvant radiotherapy for stage III\/IV urothelial carcinoma of the upper tract","volume":"34","author":"Jwa","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.purol.2014.07.002_bib0015","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0022-5347(17)44272-8","article-title":"Percutaneous management of renal pelvic tumors: a treatment option in selected cases","volume":"137","author":"Smith","year":"1987","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0020","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0022-5347(17)38957-7","article-title":"Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ","volume":"142","author":"Studer","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-5347(01)64015-1","article-title":"New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma","volume":"159","author":"Patel","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0030","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0022-5347(01)66732-6","article-title":"Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience","volume":"154","author":"Jarrett","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-5347(01)65854-3","article-title":"Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors","volume":"156","author":"Mart\u00ednez-Pi\u00f1eiro","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/0974-7796.115746","article-title":"Mitomycin\u00a0C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma","volume":"5","author":"Aboumarzouk","year":"2013","journal-title":"Urol Ann"},{"key":"10.1016\/j.purol.2014.07.002_bib0045","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0022-5347(05)64454-0","article-title":"Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery","volume":"168","author":"Thalmann","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0050","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.eururo.2011.07.051","article-title":"Antegrade perfusion with bacillus Calmette-Guerin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?","volume":"60","author":"Giannarini","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0055","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.eururo.2008.04.083","article-title":"Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy \u2013\u00a0results from a multicenter study","volume":"54","author":"Karam","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0060","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1159\/000020365","article-title":"Bacillus Calmette-Guerin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract","volume":"38","author":"Nonomura","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0065","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1442-2042.2006.01312.x","article-title":"Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guerin therapy","volume":"13","author":"Kojima","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.urology.2008.06.026","article-title":"A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette-Guerin therapy?","volume":"73","author":"Rastinehad","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.purol.2014.07.002_bib0075","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0022-5347(17)35473-3","article-title":"Technique of mitomycin\u00a0C instillation in the treatment of upper urinary tract urothelial tumors","volume":"150","author":"Eastham","year":"1993","journal-title":"J Urol"},{"year":"2014","series-title":"Hydrogel based drug retention system for the treatment of upper tract urothelial carcinoma","author":"Lifshitz","key":"10.1016\/j.purol.2014.07.002_bib0080"},{"key":"10.1016\/j.purol.2014.07.002_bib0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1464-410X.1991.tb15064.x","article-title":"Transitional cell carcinoma of the upper urinary tract: prognostic variables and post-operative recurrences","volume":"67","author":"Krogh","year":"1991","journal-title":"Br J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.juro.2009.08.154","article-title":"Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?","volume":"183","author":"Wu","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0095","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","article-title":"Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin\u00a0C (the ODMIT-C trial)","volume":"60","author":"O\u2019Brien","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0100","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","article-title":"Prospective randomized phase\u00a0II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial","volume":"31","author":"Ito","year":"2013","journal-title":"J Clin Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.purol.2014.07.002_bib0105","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S1166-7087(13)70049-6","article-title":"Recommandations en onco-urologie 2013 du CCAFU\u00a0: tumeurs de la vessie","volume":"23","author":"Pfister","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","article-title":"European guidelines on upper tract urothelial carcinomas: 2013 update","volume":"63","author":"Roupr\u00eat","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/1097-0142(19870801)60:3+<574::AID-CNCR2820601524>3.0.CO;2-C","article-title":"Chemotherapy of urothelial tract tumors","volume":"60","author":"Yagoda","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2014.07.002_bib0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.urolonc.2010.07.016","article-title":"The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC)","volume":"31","author":"Audenet","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.purol.2014.07.002_bib0125","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.2004.09.043","article-title":"Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group","volume":"22","author":"Bamias","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2014.07.002_bib0130","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/annonc\/mdl057","article-title":"A phase\u00a0II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced\/metastatic transitional cell carcinoma (TCC) of the urothelial tract","volume":"17","author":"Theodore","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.purol.2014.07.002_bib0135","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2010.32.3139","article-title":"International phase\u00a0III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial","volume":"29","author":"International Collaboration of Trialists","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2014.07.002_bib0140","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1464-410X.2011.10075.x","article-title":"Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration","volume":"108","author":"Youssef","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.07.002_bib0145","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/cncr.25050","article-title":"Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma","volume":"116","author":"Matin","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2014.07.002_bib0150","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.28655","article-title":"Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma","volume":"120","author":"Porten","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2014.07.002_bib0155","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/cncr.27751","article-title":"A phase\u00a02 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results","volume":"119","author":"Siefker-Radtke","year":"2013","journal-title":"Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.purol.2014.07.002_bib0160","article-title":"Neoadjuvant chemotherapy with DDMVAC and bevacizumab in high-risk urothelial cancer: results from a phase\u00a0II trial at the M.D.\u00a0Anderson Cancer Center","volume":"30","author":"Siefker-Radtke","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2014.07.002_bib0165","first-page":"1","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0170","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1442-2042.2008.02114.x","article-title":"Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma","volume":"15","author":"Soga","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","article-title":"Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract","volume":"68","author":"Kwak","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.purol.2014.07.002_bib0180","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1442-2042.2004.00841.x","article-title":"Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancer","volume":"11","author":"Suzuki","year":"2004","journal-title":"Int J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0185","doi-asserted-by":"crossref","first-page":"686","DOI":"10.7150\/jca.7326","article-title":"The efficacy of adjuvant chemotherapy for locally advanced upper tract urothelial cell carcinoma","volume":"4","author":"Kim","year":"2013","journal-title":"J Cancer"},{"key":"10.1016\/j.purol.2014.07.002_bib0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000092930","article-title":"Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract","volume":"77","author":"Lee","year":"2006","journal-title":"Urol Int"},{"key":"10.1016\/j.purol.2014.07.002_bib0195","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.juro.2009.05.011","article-title":"Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration","volume":"182","author":"Hellenthal","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2012.11.014","article-title":"Adjuvant chemotherapy for upper tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome","volume":"32","author":"Yafi","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.purol.2014.07.002_bib0205","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00345-011-0775-z","article-title":"The result of adjuvant chemotherapy for localized pT3 upper urinary tract carcinoma in a multi-institutional study","volume":"30","author":"Kawashima","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0210","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1002\/cncr.26172","article-title":"Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study","volume":"117","author":"Vassilakopoulou","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2014.07.002_bib0215","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","article-title":"Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy","volume":"58","author":"Kaag","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0220","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-5347(01)66563-7","article-title":"Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?","volume":"155","author":"Maulard-Durdux","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0225","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-5347(01)62763-0","article-title":"Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy","volume":"160","author":"Hall","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0230","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0022-5347(01)66330-4","article-title":"Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis","volume":"155","author":"Patel","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF01637368","article-title":"Percutaneous removal of upper tract tumours","volume":"7","author":"Nurse","year":"1989","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0240","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0022-5347(17)36117-7","article-title":"Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ","volume":"149","author":"Sharpe","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0245","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1046\/j.1464-410X.1996.09559.x","article-title":"Bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract","volume":"77","author":"Yokogi","year":"1996","journal-title":"Br J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0250","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1464-410x.2000.00610.x","article-title":"Bacillus Calmette-Guerin instillation treatment for carcinoma in situ of the upper urinary tract","volume":"85","author":"Nishino","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.07.002_bib0255","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1464-410X.2001.02297.x","article-title":"Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure","volume":"88","author":"Okubo","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2014.07.002_bib0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0090-4295(01)01488-1","article-title":"Intravesical instillation of bacille Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter","volume":"59","author":"Irie","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.purol.2014.07.002_bib0265","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1442-2042.2002.00551.x","article-title":"Clinical outcome of bacillus Calmette-Guerin perfusion therapy for carcinoma in situ of the upper urinary tract","volume":"9","author":"Miyake","year":"2002","journal-title":"Int J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0270","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.urology.2004.01.046","article-title":"Long-term effects of bacille Calmette-Guerin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract","volume":"63","author":"Hayashida","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.purol.2014.07.002_bib0275","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0094-0143(21)01586-X","article-title":"Percutaneous treatment of transitional cell carcinoma of the upper urinary tract","volume":"15","author":"Orihuela","year":"1988","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.purol.2014.07.002_bib0280","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0022-5347(17)37897-7","article-title":"The management of transitional cell carcinoma in solitary renal units","volume":"146","author":"Schoenberg","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0285","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0090-4295(99)80005-3","article-title":"Definitive tumor resection and percutaneous bacille Calmette-Guerin for management of renal pelvic transitional cell carcinoma in solitary kidneys","volume":"45","author":"Vasavada","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.purol.2014.07.002_bib0290","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0022-5347(01)61765-8","article-title":"13-year experience with percutaneous management of upper tract transitional cell carcinoma","volume":"161","author":"Clark","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0295","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0094-0143(05)70122-1","article-title":"Primary percutaneous approach to upper urinary tract transitional cell carcinoma","volume":"27","author":"Jabbour","year":"2000","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.purol.2014.07.002_bib0300","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1158\/1055-9965.EPI-08-0259","article-title":"Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway","volume":"17","author":"Margulis","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.purol.2014.07.002_bib0305","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000282755","article-title":"Neoadjuvant chemotherapy for locally advanced urothelial cancer of the upper urinary tract","volume":"55","author":"Igawa","year":"1995","journal-title":"Urol Int"},{"issue":"4","key":"10.1016\/j.purol.2014.07.002_bib0310","article-title":"Neoadjuvant accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) in patients with high-grade upper tract urothelial carcinoma","author":"Hoffman-Censits","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2014.07.002_bib0315","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0959-8049(99)00012-X","article-title":"Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study","volume":"35","author":"Ozsahin","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.purol.2014.07.002_bib0320","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1078-1439(96)00095-6","article-title":"Transitional cell carcinoma of the renal pelvis and ureter: outcome and patterns of relapse in patients treated with postoperative radiation","volume":"2","author":"Catton","year":"1996","journal-title":"Urol Oncol"},{"key":"10.1016\/j.purol.2014.07.002_bib0325","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0022-5347(17)49328-1","article-title":"The postoperative irradiation of transitional cell carcinoma of the renal pelvis and ureter","volume":"133","author":"Brookland","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2014.07.002_bib0330","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0090-4295(99)80346-X","article-title":"Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure","volume":"46","author":"Cozad","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.purol.2014.07.002_bib0335","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ju.0000137910.38441.8a","article-title":"Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter","volume":"172","author":"Czito","year":"2004","journal-title":"J Urol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708714001936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708714001936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:25:45Z","timestamp":1761114345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708714001936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":67,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1166708714001936"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2014.07.002","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitements non chirurgicaux des tumeurs de la voie excr\u00e9trice sup\u00e9rieure\u00a0: \u00e9tat-de-l\u2019art pour le rapport annuel de l\u2019Association fran\u00e7aise d\u2019urologie","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2014.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}